High Fat Diet Suppresses Peroxisome Proliferator-Activated Receptors and Reduces Dopaminergic Neurons in the Substantia Nigra
Open Access
- 27 December 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (1), 207
- https://doi.org/10.3390/ijms21010207
Abstract
Although several epidemiologic and animal studies have revealed correlations between obesity and neurodegenerative disorders, such as Parkinson disease (PD), the underlying pathological mechanisms of obesity-induced PD remain unclear. Our study aimed to assess the effect of diet-induced obesity on the brain dopaminergic pathway. For five months, starting from weaning, we gave C57BL/6 mice a high-fat diet (HFD) to generate an obese mouse model and investigate whether the diet reprogrammed the midbrain dopaminergic system. Tyrosine hydroxylase staining showed that the HFD resulted in fewer dopaminergic neurons in the substantia nigra (SN), but not the striatum. It also induced neuroinflammation, with increased astrogliosis in the SN and striatum. Dendritic spine density in the SN of HFD-exposed mice decreased, which suggested that prolonged HFD altered dopaminergic neuroplasticity. All three peroxisome proliferator-activated receptor (PPAR) subtype (PPAR-α, PPAR-β/δ, PPAR-γ) levels were significantly reduced in the SN and the ventral tegmental area of HFD mice when compared to those in controls. This study showed that a prolonged HFD induced neuroinflammation, suppressed PPAR levels, caused degeneration of midbrain dopaminergic neurons, and resulted in symptoms reminiscent of human PD. To our knowledge, this is the first study documenting the effects of an HFD on PPARs in dopaminergic neurons.Funding Information
- Ministry of Science and Technology, Taiwan (MOST-105-2628-B-006-016-MY3 and MOST-106-2628-B-006-001-MY4)
- National Cheng Kung University Hospital (NCKUH-10802021)
This publication has 72 references indexed in Scilit:
- A peroxisome proliferator-activated receptor-δ agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s diseaseNeuroscience, 2013
- Epigenetic dysregulation of the dopamine system in diet‐induced obesityJournal of Neurochemistry, 2012
- PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Peroxisome proliferation–associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesityNature Medicine, 2011
- The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeysJournal of Neuroinflammation, 2011
- A role for central nervous system PPAR-γ in the regulation of energy balanceNature Medicine, 2011
- Brain PPAR-γ promotes obesity and is required for the insulin–sensitizing effect of thiazolidinedionesNature Medicine, 2011
- Overeating Behavior and Striatal Dopamine with 6--Fluoro-L--Tyrosine PETJournal of Obesity, 2010
- Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese ratsNature Neuroscience, 2010
- Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague–Dawley ratsNeuroscience Letters, 2008